Consensus: a framework for evaluation of uncertain gene variants in laboratory test reporting

Accurate interpretation of gene testing is a key component in customizing patient therapy. Where confirming evidence for a gene variant is lacking, computational prediction may be employed. A standardized framework, however, does not yet exist for quantitative evaluation of disease association for uncertain or novel gene variants in an objective manner. Here, complementary predictors for missense gene variants were incorporated into a weighted Consensus framework that includes calculated reference intervals from known disease outcomes. Data visualization for clinical reporting is also discussed.

[1]  W G Cole.  Integrality and meaning: essential and orthogonal dimensions of graphical data display. , 1993, Proceedings. Symposium on Computer Applications in Medical Care.

[2]  Rong Mao,et al.  Multiple endocrine neoplasia type 2 RET protooncogene database: Repository of MEN2‐associated RET sequence variation and reference for genotype/phenotype correlations , 2009, Human mutation.

[3]  Ian H. Witten,et al.  Data mining in bioinformatics using Weka , 2004, Bioinform..

[4]  M. Gulley,et al.  Clinical laboratory reports in molecular pathology. , 2007, Archives of pathology & laboratory medicine.

[5]  Modesto Orozco,et al.  PMUT: a web-based tool for the annotation of pathological mutations on proteins , 2005, Bioinform..

[6]  Euan A Ashley,et al.  Challenges in the clinical application of whole-genome sequencing , 2010, The Lancet.

[7]  Guilherme Del Fiol,et al.  Integrating Genetic Information Resources with an EHR , 2006, AMIA.

[8]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[9]  E. Capriotti,et al.  Functional annotations improve the predictive score of human disease‐related mutations in proteins , 2009, Human mutation.

[10]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[11]  H. Wajcman,et al.  In silico prediction of the deleterious effect of a mutation: proceed with caution in clinical genetics. , 2004, Clinical chemistry.

[12]  Eliot Marshall.  Human genome 10th anniversary. Human genetics in the clinic, one click away. , 2011, Science.

[13]  Perry G. Ridge,et al.  Predicting Phenotypic Severity of Uncertain Gene Variants in the RET Proto-Oncogene , 2011, PloS one.

[14]  Alice S Whittemore,et al.  Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. , 2007, JAMA.

[15]  Douglas F Easton,et al.  Genetic evidence and integration of various data sources for classifying uncertain variants into a single model , 2008, Human mutation.

[16]  Nenad Blau,et al.  Mutations in the BH4‐metabolizing genes GTP cyclohydrolase I, 6‐pyruvoyl‐tetrahydropterin synthase, sepiapterin reductase, carbinolamine‐4a‐dehydratase, and dihydropteridine reductase , 2006, Human mutation.

[17]  M. Blok,et al.  Patients with an unclassified genetic variant in the BRCA1 or BRCA2 genes show different clinical features from those with a mutation. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Ellen Wright Clayton,et al.  Newborn Screening Technology: Proceed With Caution , 2006, Pediatrics.

[19]  Predrag Radivojac,et al.  Automated inference of molecular mechanisms of disease from amino acid substitutions , 2009, Bioinform..

[20]  Natalie Wilson,et al.  Human Protein Reference Database , 2004, Nature Reviews Molecular Cell Biology.

[21]  A. Rustgi,et al.  The Hereditary Nonpolyposis Colorectal Cancer Syndrome: Genetics and Clinical Implications , 2003, Annals of Internal Medicine.

[22]  Elaine Lyon,et al.  Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. , 2009, The Journal of molecular diagnostics : JMD.

[23]  Fergus J Couch,et al.  A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. , 2007, American journal of human genetics.

[24]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[25]  Matthew S. Lebo,et al.  Development and validation of a computational method for assessment of missense variants in hypertrophic cardiomyopathy. , 2011, American journal of human genetics.

[26]  A. Stiggelbout,et al.  Disentangling the Babylonian speech confusion in genetic counseling: An analysis of the reliability and validity of the nomenclature for BRCA1/2 DNA-test results other than pathogenic , 2009, Genetics in Medicine.

[27]  Jonathan AC Sterne,et al.  BMC Medical Research Methodology BioMed Central Correspondence Graphical presentation of diagnostic information , 2008 .

[28]  Mauno Vihinen,et al.  Capturing all disease-causing mutations for clinical and research use: Toward an effortless system for the Human Variome Project , 2009, Genetics in Medicine.

[29]  R. Nussbaum,et al.  MutaDATABASE: a centralized and standardized DNA variation database , 2011, Nature Biotechnology.

[30]  Joyce A. Mitchell,et al.  Computational Feature Selection and Classification of RET Phenotypic Severity , 2010 .

[31]  S. Teutsch,et al.  Outcomes of interest in evidence-based evaluations of genetic tests , 2010, Genetics in Medicine.

[32]  C Li,et al.  Personalized medicine – the promised land: are we there yet? , 2011, Clinical genetics.

[33]  E. Lyon,et al.  Likelihood ratios to assess genetic evidence for clinical significance of uncertain variants: hereditary hemorrhagic telangiectasia as a model. , 2008, Experimental and molecular pathology.

[34]  G. Javitt,et al.  Developing the Blueprint for a Genetic Testing Registry , 2009, Public Health Genomics.

[35]  Heidi L Rehm,et al.  Use and interpretation of genetic tests in cardiovascular genetics , 2010, Heart.

[36]  M. Corey,et al.  Understanding the population structure of North American patients with cystic fibrosis , 2011, Clinical genetics.

[37]  Joyce A. Mitchell,et al.  Utility of gene-specific algorithms for predicting pathogenicity of uncertain gene variants , 2012, J. Am. Medical Informatics Assoc..

[38]  Alexander A. Morgan,et al.  Clinical assessment incorporating a personal genome , 2010, The Lancet.

[39]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[40]  Sean V Tavtigian,et al.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Natalie Wilson.  Human Protein Reference Database , 2004, Nature Reviews Genetics.

[42]  Kelli Sumner,et al.  The Alport syndrome COL4A5 variant database , 2010, Human mutation.

[43]  M Joan Saary,et al.  Radar plots: a useful way for presenting multivariate health care data. , 2008, Journal of clinical epidemiology.

[44]  W. Otten,et al.  Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message. , 2004, Genetic testing.

[45]  W. Grody,et al.  ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 , 2008, Genetics in Medicine.

[46]  Rong Mao,et al.  Mutation database for the galactose‐1‐phosphate uridyltransferase (GALT) gene , 2007, Human mutation.

[47]  M. A. Hoffman,et al.  The genome-enabled electronic medical record , 2007, J. Biomed. Informatics.

[48]  Guy A. Rouleau,et al.  The case for locus-specific databases , 2011, Nature Reviews Genetics.

[49]  A. Spurdle,et al.  Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.

[50]  Mark Yandell,et al.  Global analysis of disease-related DNA sequence variation in 10 healthy individuals: Implications for whole genome-based clinical diagnostics , 2011, Genetics in Medicine.